Mimic of manganese superoxide dismutase induces apoptosis in human acute myeloid leukemia cells

References

• Roboz GJ. Treatment of acute myeloid leukemia in older patients. Expert Rev Anticancer Ther 2007;7:285–295.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005;106:1154–1163.
   PubMed Web of Science ®Google Scholar
• Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukemia. Mayo Clinic Proc 2006;81:247–260.
   PubMed Web of Science ®Google Scholar
• Novotny L, Szekeres T. Cancer therapy: new targets for chemotherapy. Hematology 2003;8:129–137.
   PubMedGoogle Scholar
• Honea N, Brant J, Beck SL. Treatment-related symptom clusters. Semin Oncol Nurs 2007;23:142–151.
   PubMedGoogle Scholar
• Zhong W, Yan T, Webber MM, et al. Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells. Antioxid Redox Signal 2004;6:513–522.
   PubMed Web of Science ®Google Scholar
• van de Wetering CI, Coleman MC, Spitz DR, et al. Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma. Free Radic Biol Med 2008;44:1677–1686.
   PubMed Web of Science ®Google Scholar
• Weydert C, Roling B, Liu J, et al. Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dismutase. Mol Cancer Therap 2003;2: 361–369.
   PubMed Web of Science ®Google Scholar
• Venkataraman S, Jiang X, Weydert C, et al. Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005;24:77–89.
   PubMed Web of Science ®Google Scholar
• Li N, Oberley TD, Oberley LW, et al. Over-expression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate 1998;35:221–233.
   PubMed Web of Science ®Google Scholar
• Fan LL, Wei HL, Dou W, et al. The apoptosis-inducing effect of MnSODm on K562 cells and its molecular mechanism. Chin Pharmacol Bull 2009;29:2248–2251.
   Google Scholar
• Wang YH, Yang XL, Xia H, et al. Mimic of manganese superoxide dismutase to induce apoptosis of human non-Hodgkin lymphoma Raji cells through mitochondrial pathways. Int Immunopharmacol 2012;14:620–628.
   PubMed Web of Science ®Google Scholar
• Rivero A, Quintana J, Eiroa JL, et al. Potent induction of apoptosis by germacranolide sesquiterpene lactones on human myeloid leukemia cells. Eur J Pharmacol 2003;482:77–84.
   PubMed Web of Science ®Google Scholar
• Hagiwara Y, Kasukabe T, Kaneko Y, et al. Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. Int J Hematol 2010;92:136–143.
   PubMed Web of Science ®Google Scholar
• Lv W, Sheng X, Chen T, et al. Jaceosidin induces apoptosis in human ovary cancer cells through mitochondrial pathway. J Biomed Biotechnol 2008;2008:394802.
   PubMed Web of Science ®Google Scholar
• Cline JM, Hughes CL Jr. Phytochemicals for the prevention of breast and endometrial cancer. Cancer Treat Res 1998;94: 107–134.
   PubMedGoogle Scholar
• Wang J, Ito T, Ukada N, et al. PI3K-AKT pathway mediates growth and survival signals during development of fetal mouse lung. Tissue Cell 2006;37:25–35.
   Web of Science ®Google Scholar
• Kim MS, Kang HJ, Moon A. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch Pharmacol Res 2001;24:349–354.
   PubMed Web of Science ®Google Scholar
• Wenzel U, Kuntz S, Brendel MD, et al. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res 2000;60:3823–3831.
   PubMed Web of Science ®Google Scholar
• Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001;7:314–319.
   PubMed Web of Science ®Google Scholar
• Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000;10:369–377.
   PubMed Web of Science ®Google Scholar
• van Loo G, Saelens X, van Gurp M, et al. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 2002;9:1031–1042.
   PubMed Web of Science ®Google Scholar
• Antonsson B. Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways. Mol Cell Biochem 2004;256–257:141–155.
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y. Bcl-2 family of proteins: life-or-death switch in mitochondria. Biosci Rep 2002;22:47–58.
   PubMed Web of Science ®Google Scholar
• Bossy-Wetzel E, Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999;274:17484–17490.
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489–501.
   PubMed Web of Science ®Google Scholar
• Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 2001;98:10983–10985.
   PubMed Web of Science ®Google Scholar
• Lawlor MA, Alessi DR. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?J Cell Sci 2001;114:2903–2910.
   PubMed Web of Science ®Google Scholar
• Wu T, Leng J, Han C, et al. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Mol Cancer Ther 2004;3:299–307.
   PubMed Web of Science ®Google Scholar